Bridgewater Associates, LP

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1350694 Westport, CT

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$29,977,771

-$5,290,324 QoQ

Shares Held

99,584

-6.6% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#108

of 784 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgewater Associates, LP holds $347,338,125 across 26 Biotechnology names. ALNY ranks #5 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	455,392	$48,553,895
2	HALO	Halozyme Therapeutics, Inc.	463,146	$36,250,437
3	BBIO	BridgeBio Pharma, Inc.	448,143	$33,377,690
4	REGN	Regeneron Pharmaceuticals, Inc.	51,333	$32,008,178
5	ALNY	Alnylam Pharmaceuticals, Inc. This page	99,584	$29,977,771
6	TGTX	Tg Therapeutics, Inc.	429,904	$23,618,925
7	EXEL	Exelixis, Inc.	400,859	$21,810,738
8	KRYS	Krystal Biotech, Inc.	54,489	$20,251,926

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,977,771	99,584	-6.6%	Shares	Sole	2026-08-14
2026-03-31	$35,268,095	106,592	+24.5%	Shares	Sole	2026-05-15
2025-12-31	$34,045,600	85,617	+152.5%	Shares	Sole	2026-02-13
2025-09-30	$15,463,416	33,911	+425.6%	Shares	Sole	2025-11-13
2024-12-31	$1,518,220	6,452	+222.3%	Shares	Sole	2025-02-13
2024-09-30	$550,610	2,002	+2.6%	Shares	Sole	2024-11-13
2023-12-31	$373,440	1,951	+3.4%	Shares	Sole	2024-02-14
2023-09-30	$334,010	1,886	+5.0%	Shares	Sole	2023-11-13
2023-06-30	$341,132	1,796	+43.1%	Shares	Sole	2023-08-11
2023-03-31	$251,401	1,255	-2.2%	Shares	Sole	2023-05-12
2022-09-30	$256,805	1,283	-15.1%	Shares	Sole	2022-11-10
2022-06-30	$220,525	1,512	-32.3%	Shares	Sole	2022-08-11
2021-09-30	$421,801	2,234	-63.4%	Shares	Sole	2021-11-12
2021-06-30	$1,033,902	6,099	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.